Picture of Orexo AB logo

ORX Orexo AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Orexo AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line231-19.9-214-184-110
Depreciation
Non-Cash Items0.3-46-69.8-72.222.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital14.543.7230.8-85.3
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities28716.7-229-157-95
Capital Expenditures-32-190-52.8-23.9-19.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items9.60.6-0.1-211220
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-22.4-189-52.9-235201
Financing Cash Flow Items0.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-53.7-111251-21.4-70.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash227-312-1.2-37238.8